Showing 1–25 of 200 documents
Sorted by hybrid relevance (keyword + semantic via RRF)
World Health Organization. Regional Office for Europe
…Region has the highest rates in the world of drug-resistant tuberculosis and increasing rates of HIV/tuberculosis coinfection. Eighteen high-priority countries have been identified to urgently scale up tuberculosis control interventions: Armenia, Azerbaijan, Belarus, Bulgaria, Es…
World Health Organization
This web annex to the WHO consolidated guidance on tuberculosis data generation and use presents the second edition of the checklist for assessing tuberculosis (TB) surveillance and vital registration systems. The document aims to support countries in evaluating whether their sur…
World Health Organization
This web annex to the WHO consolidated guidance on tuberculosis data generation and use summarizes the findings of a retrospective evaluation of the WHO DHIS2 case-based package for tuberculosis surveillance, known as the “TB tracker”, implemented in five pilot countries: Ghana, …
World Health Organization. Regional Office for Europe
The European Tuberculosis Laboratory Initiative (ELI), with its secretariat at the WHO Regional Office for Europe, has developed this technical document to address the need in the WHO European Region for increasing timely and accurate detection of tuberculosis (TB) and multidrug-…
World Health Organization
…entation guide provides operational guidance for conducting tuberculosis (TB) epidemiological reviews and assessments of TB surveillance and vital registration systems within the framework of national TB programme reviews. The document describes the rationale, objectives and meth…
Expert Group on TB Recording and Reporting Forms and Registers, World Health Organization, World Health Organization
World Health Organization
World Health Organization. Regional Office for Europe
Ending tuberculosis by 2030 requires not only strong health systems but also investments in rights-based, people-centred care. This document was developed in the framework of the project Advancing people-centred quality tuberculosis care: TB-REP, which was funded by the Global Fu…
Ahamed, Nisha, Yurasova, Yelena, Zaleskis, Richard, Grzemska, Malgorzata, Reichman, Lee B, et al.
Tuberculosis is an increasingly serious problem in the WHO European region, particularly in the countries of eastern Europe, the Baltic States, and the Commonwealth of Independent States (CIS).Primary health care providers can play an important role in tuberculosis control throug…
World Health Organization
Tuberculosis imposes a substantial economic burden on affected individuals and households, often leading to catastrophic costs that hinder access to care and successful treatment outcomes. This document presents updated WHO guidance within the consolidated framework on tuberculos…
Dara, Masoud, Gozalov, Ogtay, World Health Organization. Regional Office for Europe
…e on the “Programmatic aspects of the implementation of new tuberculosis drugs and regimens” co-organized with the Laboratories, Diagnostics and Drug-resistance team of the Global TB Programme (GTB). The objective of the rGLC/Europe meeting and following workshop were to discuss …
World Health Organization. Regional Office for Europe
While decreasing trends in tuberculosis (TB) incidence and mortality rates represent major achievements in TB prevention and care in the WHO European Region and eastern Europe and central Asia (EECA), the still alarmingly high rates of drug-resistant TB (DR-TB) and of TB/HIV coin…
World Health Organization. Regional Office for Europe
…been published at the global and European levels to support tuberculosis (TB) elimination and the management of TB infection. These warrant a review of the available reports and their implications for the WHO European Region. This publication aims to guide Member States in the Re…
World Health Organization. Regional Office for Europe
…ized package of community-based support services to improve tuberculosis outcomes and is aimed to provide the national stakeholders such as the ministries of health, National Tuberculosis Programmes (NPTs) and civil society organizations in eastern Europe and central Asia with a …
World Health Organization
This web annex to the WHO consolidated guidance on tuberculosis data generation and use provides standardized templates and formulae for the reporting of aggregated tuberculosis (TB) surveillance data and the calculation of core indicators. The document is intended to support con…
World Health Organization. Regional Office for Europe
…est proportion of multidrug- and extensively drug-resistant tuberculosis (M/XDR-TB) patients in the world. The Consolidated Action Plan to Prevent and Combat Multidrug- and Extensively Drug-Resistant Tuberculosis in the WHO European Region, 2011–2015 was developed in 2011 and in …
World Health Organization. Regional Office for Europe
… to the burden of multidrug- and extensively drug-resistant tuberculosis (M/XDR-TB), all 53 Member States in the WHO European Region endorsed the Consolidated Action Plan to Prevent and Combat Multidrug- and Extensively Drug-resistant Tuberculosis in the WHO European Region 2011–…
World Health Organization
…his web annex examines commonly observed problems affecting tuberculosis (TB) surveillance systems and presents proposed solutions based on findings from WHO-supported epidemiological reviews conducted in multiple countries between 2013 and 2020. Prepared as part of the WHO conso…
World Health Organization. Regional Office for Europe
… Regional Collaborating Committee to accelerate response to Tuberculosis, HIV and viral Hepatitis, (RCC-THV), organized by WHO Regional Office for Europe, took place on 11 April 2019 in Copenhagen, Denmark. The overall objective was to provide an interactive platform for donors, …
World Health Organization
…or the design, implementation, analysis and use of national tuberculosis (TB) prevalence surveys. Developed as Module 3 of the consolidated guidance on tuberculosis data generation and use, the publication addresses the role of prevalence surveys in measuring the burden of TB dis…
ten Dam, H. G.
…des technical guidance on the use of tuberculin surveys for tuberculosis surveillance and epidemiological assessment. It reviews the principles underlying tuberculin testing, including the interpretation of reaction patterns, the distinction between specific and non-specific sens…
Abu Taleb, A.M.F., El Sokkary, R.H., El Tarhouny, S.A.
…test [TST] has many limitations for the diagnosis of latent tuberculosis [TB] infection. The aim of this study in Egypt was to estimate the usefulness of an interferon-gamma release assay [IFN-gamma] assay for the detection of latent TB infection in contacts of active TB cases. A…
World Health Organization. Regional Office for Europe
…arming problem of multidrug- and extensively drug-resistant tuberculosis (M/XDR-TB) in the WHO European Region, and in order to scale up a comprehensive response and to prevent and control M/XDR-TB, a consolidated action plan has been developed for 2011–2015 for all 53 Member Sta…
World Health Organization
…ce on the implementation of record-linkage exercises within tuberculosis (TB) surveillance systems, particularly in countries adopting digital case-based surveillance. It explains the role of record linkage in identifying individuals diagnosed with TB who are not linked to treatm…
World Health Organization. Regional Office for Europe
An increase in tuberculosis (TB) and drug-resistant TB notifications was reported by Czechia to WHO in 2022 and observed over the first 10 months of 2023. This pointed to a recovery of the country’s health system from the impact of COVID-19, in addition to increased migration pro…